First Header Logo Second Header Logo

William Petty

Concepts (140)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
14
2018
410
1.500
Why?
Carcinoma, Non-Small-Cell Lung
7
2018
101
1.100
Why?
Quinazolines
4
2013
38
0.880
Why?
Neoplasms, Vascular Tissue
1
2012
7
0.430
Why?
Knee Prosthesis
1
2012
15
0.420
Why?
Hypoxia-Inducible Factor 1, alpha Subunit
1
2012
23
0.420
Why?
Antineoplastic Agents
5
2018
608
0.410
Why?
Osteoarthritis, Knee
1
2012
90
0.400
Why?
Sarcoma
1
2012
73
0.400
Why?
Periodicals as Topic
1
2012
91
0.380
Why?
Arthroplasty, Replacement, Knee
1
2012
89
0.380
Why?
Gastrointestinal Neoplasms
1
2011
33
0.370
Why?
Angiotensin I
1
2012
241
0.360
Why?
Carcinoma
1
2011
92
0.360
Why?
Peptide Fragments
1
2012
399
0.340
Why?
Antineoplastic Combined Chemotherapy Protocols
5
2018
461
0.290
Why?
Aged
14
2018
10334
0.230
Why?
Adenocarcinoma
3
2017
312
0.230
Why?
Middle Aged
15
2018
11847
0.230
Why?
Radiosurgery
4
2017
356
0.230
Why?
Protein Kinase Inhibitors
3
2017
85
0.220
Why?
Brain Neoplasms
3
2017
638
0.220
Why?
Gene Expression Profiling
3
2017
322
0.210
Why?
Cyclin D3
2
2013
4
0.210
Why?
Cyclin D1
2
2013
14
0.210
Why?
Humans
21
2018
32041
0.210
Why?
Disease-Free Survival
4
2017
319
0.200
Why?
Aged, 80 and over
8
2018
3998
0.200
Why?
Retrospective Studies
8
2018
3526
0.190
Why?
Adult
10
2018
9358
0.190
Why?
Male
15
2018
19195
0.180
Why?
Treatment Outcome
5
2017
3315
0.180
Why?
Female
15
2018
19994
0.180
Why?
Neoplasm Invasiveness
2
2017
195
0.170
Why?
Carboplatin
1
2018
48
0.160
Why?
Paclitaxel
1
2018
67
0.160
Why?
Nervous System Diseases
1
2018
39
0.150
Why?
Immunotherapy
1
2018
81
0.150
Why?
Neoplastic Cells, Circulating
1
2017
23
0.140
Why?
DNA, Neoplasm
1
2017
55
0.140
Why?
Fetal Proteins
1
2016
7
0.140
Why?
Receptor, Fibroblast Growth Factor, Type 1
1
2016
10
0.140
Why?
T-Box Domain Proteins
1
2016
14
0.140
Why?
Sulfides
1
2016
27
0.140
Why?
Small Cell Lung Carcinoma
1
2016
17
0.140
Why?
Caprylates
1
2016
28
0.140
Why?
Hospice Care
1
2016
13
0.140
Why?
Terminal Care
1
2016
24
0.140
Why?
Smoking
2
2017
496
0.140
Why?
Taxoids
2
2013
59
0.130
Why?
Drug Administration Schedule
2
2013
276
0.130
Why?
Palliative Care
1
2016
52
0.130
Why?
Mice
2
2012
2485
0.130
Why?
Neoplasms
3
2018
724
0.130
Why?
Spermatogenesis
1
2016
47
0.130
Why?
Cryopreservation
1
2016
57
0.130
Why?
Testis
1
2016
65
0.130
Why?
Neoplasm Metastasis
1
2016
221
0.130
Why?
Tomography Scanners, X-Ray Computed
1
2015
10
0.130
Why?
Neoplasm Recurrence, Local
2
2016
370
0.120
Why?
Lung
1
2016
247
0.120
Why?
Mutation
1
2017
489
0.120
Why?
Dapsone
1
2014
4
0.120
Why?
Mediastinal Neoplasms
1
2014
13
0.120
Why?
Anemia, Hemolytic
1
2014
7
0.120
Why?
Cell Proliferation
2
2016
604
0.120
Why?
Hydroxamic Acids
1
2014
21
0.120
Why?
Filgrastim
1
2013
4
0.120
Why?
Thorax
1
2014
30
0.110
Why?
Survival
1
2013
13
0.110
Why?
Radiotherapy, Conformal
2
2012
19
0.110
Why?
Granulocyte Colony-Stimulating Factor
1
2013
24
0.110
Why?
Academic Medical Centers
1
2015
160
0.110
Why?
Carcinoma, Small Cell
1
2013
25
0.110
Why?
Polyethylene Glycols
1
2013
64
0.110
Why?
Cisplatin
1
2013
77
0.110
Why?
Salvage Therapy
1
2014
134
0.110
Why?
Attitude of Health Personnel
1
2015
183
0.110
Why?
Recombinant Proteins
1
2013
247
0.110
Why?
Cementation
1
2012
1
0.110
Why?
Esophagitis
1
2012
5
0.110
Why?
Pregnancy Proteins
1
2012
13
0.110
Why?
Follow-Up Studies
3
2014
2279
0.110
Why?
Esophagus
1
2012
22
0.100
Why?
Prosthesis Design
1
2012
97
0.100
Why?
Glioblastoma
1
2014
156
0.100
Why?
Carcinoma, Squamous Cell
1
2013
154
0.100
Why?
Cyclin E
1
2011
5
0.100
Why?
Biomarkers, Pharmacological
1
2011
5
0.100
Why?
Analysis of Variance
1
2012
463
0.100
Why?
NIH 3T3 Cells
1
2011
43
0.100
Why?
Health Knowledge, Attitudes, Practice
1
2015
353
0.100
Why?
Drug Resistance, Neoplasm
1
2011
104
0.090
Why?
Animals
2
2012
7543
0.090
Why?
Immunohistochemistry
1
2011
539
0.080
Why?
Astrocytoma
1
2008
29
0.080
Why?
Time Factors
1
2012
2151
0.070
Why?
Survival Rate
3
2016
886
0.070
Why?
Neoplasm Staging
3
2014
456
0.070
Why?
Cell Line, Tumor
2
2016
726
0.060
Why?
Cohort Studies
2
2018
1822
0.050
Why?
Radiotherapy Dosage
2
2014
101
0.050
Why?
Combined Modality Therapy
2
2014
564
0.050
Why?
Prognosis
2
2014
1506
0.040
Why?
Genes, erbB-1
1
2017
15
0.040
Why?
Clone Cells
1
2017
36
0.040
Why?
Genes, Neoplasm
1
2017
18
0.040
Why?
Genes, p53
1
2017
23
0.040
Why?
Genes, ras
1
2017
26
0.040
Why?
Sequence Analysis, DNA
1
2017
137
0.040
Why?
Topotecan
1
2016
17
0.040
Why?
MAP Kinase Signaling System
1
2016
61
0.030
Why?
Neoplastic Stem Cells
1
2017
99
0.030
Why?
Tissue Banks
1
2016
15
0.030
Why?
Proportional Hazards Models
1
2018
757
0.030
Why?
Neoplasm Proteins
1
2017
148
0.030
Why?
Infertility, Male
1
2016
24
0.030
Why?
Survival Analysis
1
2017
488
0.030
Why?
Geriatric Assessment
1
2018
391
0.030
Why?
Prevalence
1
2018
982
0.030
Why?
Patient Care Team
1
2016
130
0.030
Why?
Disease Progression
1
2017
593
0.030
Why?
Age Factors
1
2018
1192
0.030
Why?
Radiation Dosage
1
2015
84
0.030
Why?
Early Detection of Cancer
1
2015
89
0.030
Why?
Radiography
1
2015
376
0.030
Why?
Hospitalization
1
2016
469
0.030
Why?
Signal Transduction
1
2016
682
0.030
Why?
Tracheoesophageal Fistula
1
2012
5
0.030
Why?
Remission Induction
1
2012
84
0.030
Why?
Infant
1
2016
1059
0.030
Why?
Treatment Failure
1
2012
163
0.030
Why?
Chemotherapy, Adjuvant
1
2012
192
0.030
Why?
Child, Preschool
1
2016
1269
0.030
Why?
Maximum Tolerated Dose
1
2010
63
0.020
Why?
Child
1
2016
2437
0.020
Why?
Imaging, Three-Dimensional
1
2010
132
0.020
Why?
Adolescent
1
2016
3543
0.020
Why?
United States
1
2016
3942
0.020
Why?
Clinical Trials as Topic
1
2008
301
0.020
Why?
Petty's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (140)
Explore
_
Co-Authors (55)
Explore
_
Similar People (49)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_